MedPath

Progestron in treatment traumatic brain injury

Phase 2
Conditions
Diffuse Brain Injury.
Diffuse Brain Injury
Registration Number
IRCT2014123020487N1
Lead Sponsor
Ahvaz Jundi Shapour University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

The patients who suffered from sever traumatic brain injury that reffered to emergency departemant; They have Glasscow coma scale 4 to 8; They were not undergo surgery for any reason; They were not suffered from cardiopulmonary arrest

Exclusion criteria: The patient who that undergo surgery for any reason; females who are pregnant

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Average Glosscow coma scale. Timepoint: preaddmition, 6 th day, 3 month after addmition. Method of measurement: Glosscow coma scale.
Secondary Outcome Measures
NameTimeMethod
Average Glosscow outcome scale. Timepoint: At discharge time, 3 month later. Method of measurement: Glasscow outcome scale.;Duration of admission in intensive care unit before and after treatment in control and treatment group. Timepoint: In admission period. Method of measurement: Number of admission days.
© Copyright 2025. All Rights Reserved by MedPath